← Eichor
Study identifier: NCT06426836 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

Condition: Pharmacokinetics · Amoxicillin-clavulanate · Piperacillin-tazobactam  ·  Sponsor: University Hospital, Ghent

PhaseNA
Planned participants300
Who can joinAll sexes, N/A to 15 Years
Healthy volunteersNo

About this study

Pharmacokinetics of antibiotics in critically ill neonates, infants and children on extracorporeal membrane oxygenation (ECMO).

This description comes directly from the study's public registry record.

Talk to the study team

Pieter De Cock, PharmD  ·  +32 9 332 29 69  ·  pieter.decock@uzgent.be

Always discuss trial participation with your own doctor first.

Locations (3)

Queen Fabiola Children's University HospitalBrussels, Brussels Capital, BelgiumRecruiting
University HospitalGhent, BelgiumRecruiting
Universitair hospitalLeuven, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06426836